On 24 June 2014
Dr Reddys Laboratories announced the launch of Paricalcitol Capsules in the strengths of 1mcg, 2mcg and 4mcg, a therapeutic equivalent generic version of ZEMPLAR (Paricalcitol) Capsules in the US market on 24 June 2014, following approval by the US Food & Drug Administrator (USFDA).Powered by Capital Market - Live News